Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue

Autor: Hiroshi Kudo, Masakiyo Sasahara, Yutaka Yata, Seiichi Morita, Toshiro Sugiyama, Yasuhiro Nakayama, Terumi Takahara, Masami Kanayama, Takeshi Oya, Derek A. Mann, Kengo Kawai
Rok vydání: 2009
Předmět:
Zdroj: Liver International. 29:988-996
ISSN: 1478-3231
1478-3223
DOI: 10.1111/j.1478-3231.2009.02006.x
Popis: Background/Aims: Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH) are the hepatic manifestation of metabolic syndrome. However, its therapeutic strategy has not been established. Recently, an angiotensin II type 1 receptor blocker, telmisartan (Tel), has received a great deal of attention as a therapeutic tool for metabolic syndrome. The aim of this study was to investigate the efficacy and mechanisms of Tel on a murine NASH model. Methods: C57BL/6 mice were fed a methionine- and choline-deficient high-fat diet (MCDHF) or a standard diet with/without the administration of Tel (10 mg/kg/day) for 8 weeks. Results: MCDHF feeding induced marked steatohepatitis with macrophage infiltration. Tel attenuated liver steatosis with decreased hepatic triglycerides (P
Databáze: OpenAIRE